The findings support that all cell populations within the implant are in a post mitotic state, meaning there was no evidence ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cellino and Matricelf (TASE: MTLF) announced today a collaboration to accelerate the global biomanufacturing of personalized spinal cord injury treatments using ...
Matricelf Ltd. (TASE: MTLF), a biotechnology company developing personalized regenerative therapies, today announced that it was awarded 1st place at the prestigious Innovation Exchange Award and ...
Add Yahoo as a preferred source to see more of our stories on Google. Prof. Tal Dvir says the first recipient of the new technology will be Israeli. (CREDIT: Matricelf) For generations, paralysis from ...
TEL AVIV, Israel, Feb. 7, 2022 /PRNewswire/ -- Matricelf (TASE:MTLF) announced today that scientists from Sagol Center for Regenerative Biotechnology at Tel Aviv University have engineered 3D spinal ...
PHOENIX and NESS ZIONA, Israel, Feb. 26, 2026 /PRNewswire/ -- Matricelf Ltd. (TASE: MTLF), a regenerative medicine company advancing personalized curative treatments for spinal cord injury, announced ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
Add Yahoo as a preferred source to see more of our stories on Google. DTRAX X-ray (photo credit: COURTESY SAMSON ASSUTA ASHDOD MEDICAL CENTER) Tel Aviv University announced on Wednesday that the ...
Cellino successfully manufactures and delivers autologous iPSC lines from four donors to Matricelf for groundbreaking neural tissue engineering CAMBRIDGE, Mass., March 11, 2025--(BUSINESS ...
Matricelf Ltd. is a biotechnology company, which engages in research and development of a platform for autologous matrix and cell implants in the field of regenerative medicine and tissue engineering.
Matricelf Ltd. Annual stock financials by MarketWatch. View the latest MTRLF financial statements, income statements and financial ratios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results